As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...
Red backed shrikes migrate using a fixed schedule, flying in stages with little variation, showing that genetics guide bird ...
Red-backed shrikes fly thousands of kilometers to reach Africa—and they do so with astonishing precision. Aided by new ...
Initial favorable safety profile demonstrated in OPGx-BEST1 clinical trialRESEARCH TRIANGLE PARK, N.C., Dec. 09, 2025 (GLOBE ...
EPFL scientists have identified a molecular pathway that protects cells from lipid oxidation and ferroptosis, a regulated ...
Clinically meaningful lung function activity, measured by ppFEV1 and LCI2.5,with follow-up through 1 year at dose selected for Phase 2 Durable ...
A new genetic mapping strategy reveals how entire networks of genes work together to cause disease, filling in the missing ...
Experts and Congressmembers push to national forefront many of the issues that consume sports parents, offer potential ...
The rapid expansion of high-throughput sequencing technologies has generated unprecedented amounts of multi-omics data, ...
San Diego–based Ventyx Biosciences has what pharma wants, according to William Blair: two NLRP3 inhibitors for inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback